XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Revenue (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Disaggregation of Revenue [Line Items] |
Disaggregation of Revenue [Table Text Block] | In the following tables, revenue is disaggregated by primary geographical markets and major goods and service lines.
| Reportable Segments
| Three Months Ended
| June 30, 2024 |  | July 2, 2023
| Life Sciences |  | Diagnostics |  | Total |  | Life Sciences |  | Diagnostics |  | Total
| (In thousands)
Primary geographical markets |  |  |  |  |  |  |  |  |  |  |
Americas | $ | 168,413 |  |  | $ | 139,370 |  |  | $ | 307,783 |  |  | $ | 184,795 |  |  | $ | 134,032 |  |  | $ | 318,827 |
Europe | 67,358 |  |  | 117,230 |  |  | 184,588 |  |  | 74,707 |  |  | 116,910 |  |  | 191,617 |
Asia | 78,076 |  |  | 121,238 |  |  | 199,314 |  |  | 76,851 |  |  | 121,771 |  |  | 198,622 |
| $ | 313,847 |  |  | $ | 377,838 |  |  | $ | 691,685 |  |  | $ | 336,353 |  |  | $ | 372,713 |  |  | $ | 709,066 |
Major goods/service lines |  |  |  |  |  |  |  |  |  |  |
Life Sciences reagents | $ | 176,852 |  |  | $ | — |  |  | $ | 176,852 |  |  | $ | 192,208 |  |  | $ | — |  |  | $ | 192,208 |
Life Sciences instruments | 86,252 |  |  | — |  |  | 86,252 |  |  | 100,101 |  |  | — |  |  | 100,101 |
Life Sciences software | 50,743 |  |  | — |  |  | 50,743 |  |  | 44,044 |  |  | — |  |  | 44,044 |
Reproductive health | — |  |  | 129,175 |  |  | 129,175 |  |  | — |  |  | 128,621 |  |  | 128,621 |
Applied genomics | — |  |  | 51,287 |  |  | 51,287 |  |  | — |  |  | 59,097 |  |  | 59,097 |
Immunodiagnostics | — |  |  | 197,376 |  |  | 197,376 |  |  | — |  |  | 184,995 |  |  | 184,995 |
| $ | 313,847 |  |  | $ | 377,838 |  |  | $ | 691,685 |  |  | $ | 336,353 |  |  | $ | 372,713 |  |  | $ | 709,066 |
| Reportable Segments
| Six Months Ended
| June 30, 2024 |  | July 2, 2023
| Life Sciences |  | Diagnostics |  | Total |  | Life Sciences |  | Diagnostics |  | Total
| (In thousands)
Primary geographical markets |  |  |  |  |  |  |  |  |  |  |
Americas | $ | 324,741 |  |  | $ | 277,396 |  |  | $ | 602,137 |  |  | $ | 348,649 |  |  | $ | 272,206 |  |  | $ | 620,855 |
Europe | 137,003 |  |  | 226,147 |  |  | 363,150 |  |  | 154,992 |  |  | 221,522 |  |  | 376,514 |
Asia | 155,140 |  |  | 221,178 |  |  | 376,318 |  |  | 161,153 |  |  | 225,409 |  |  | 386,562 |
| $ | 616,884 |  |  | $ | 724,721 |  |  | $ | 1,341,605 |  |  | $ | 664,794 |  |  | $ | 719,137 |  |  | $ | 1,383,931 |
Major goods/service lines |  |  |  |  |  |  |  |  |  |  |
Life Sciences reagents | $ | 354,077 |  |  | $ | — |  |  | $ | 354,077 |  |  | $ | 382,086 |  |  | $ | — |  |  | $ | 382,086 |
Life Sciences instruments | 167,162 |  |  | — |  |  | 167,162 |  |  | 196,275 |  |  | — |  |  | 196,275 |
Life Sciences software | 95,645 |  |  | — |  |  | 95,645 |  |  | 86,433 |  |  | — |  |  | 86,433 |
Reproductive health | — |  |  | 253,050 |  |  | 253,050 |  |  | — |  |  | 250,742 |  |  | 250,742 |
Applied genomics | — |  |  | 98,734 |  |  | 98,734 |  |  | — |  |  | 122,507 |  |  | 122,507 |
Immunodiagnostics | — |  |  | 372,937 |  |  | 372,937 |  |  | — |  |  | 345,888 |  |  | 345,888 |
| $ | 616,884 |  |  | $ | 724,721 |  |  | $ | 1,341,605 |  |  | $ | 664,794 |  |  | $ | 719,137 |  |  | $ | 1,383,931 |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration